Lexicon Pharmaceuticals
LXRX
#7256
Rank
โ‚น43.32 B
Marketcap
โ‚น119.23
Share price
0.00%
Change (1 day)
57.87%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.16. In 2024 the company made an earnings per share (EPS) of -โ‚น57.81 an increase over its 2023 EPS that were of -โ‚น72.26.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.63%
2024-โ‚น57.81-20%
2023-โ‚น72.2631.15%
2022-โ‚น55.10-0%
2021-โ‚น55.1010.91%
2020-โ‚น49.68-145.08%
2019โ‚น110.19-206.09%
2018-โ‚น103.87-5.74%
2017-โ‚น110.19-10.95%
2016-โ‚น123.742640%
2015-โ‚น4.52-96.34%
2014-โ‚น123.25-2.53%
2013-โ‚น126.45-9.09%
2012-โ‚น139.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น6,929 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,924-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น536.51 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น245.68-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น1,566-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น48.77 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น403.74-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น215.87-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.74 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA